Lv51
1120 积分 2021-11-26 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
5天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
5天前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
Soft robotic apparel to avert freezing of gait in Parkinson's disease
1个月前
已完结
Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy
1个月前
已完结
Sustained amphiregulin expression in intermediate alveolar stem cells drives progressive fibrosis
1个月前
已完结
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
1个月前
已完结
afety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients
5个月前
已完结
Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China
5个月前
已完结
Reply to: "Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?"
6个月前
已完结
皖公网安备34019202002308
